Related Experiment Video
Updated: May 17, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.0K
Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective
Deborah A Hall1, Josh M Shulman2, Andrew Singleton3,4
1Department of Neurological Sciences, Rush University, Chicago, IL, United States.
JMIR Research Protocols
|April 7, 2025
Summary
This study compares Parkinson disease (PD) in Black and White patients, examining symptoms and quality of life. It aims to address health disparities and understand genetic factors in the Black PD community.
Area of Science:
- Neurology
- Genetics
- Health Disparities
Background:
- Parkinson disease (PD) research is predominantly based on White populations.
- Limited data exists on PD manifestation and progression in Black communities.
- Existing studies suggest Black patients with PD experience greater disability and disease severity.
Purpose of the Study:
- To investigate motor and nonmotor symptoms in Black and White patients with PD.
- To assess quality of life differences between racial groups with PD.
- To explore PD management and genetic risk factors in the Black PD population.
Main Methods:
- Observational, prospective, multicenter, case-case design.
- Recruitment of 400 Black and 200 White participants with PD across 7 US sites.
- Data analysis using linear multivariate regression and chi-square/Fisher exact tests.
Main Results:
- Project approved by Rush Institutional Review Board in February 2022.
- Funded by the National Institute of Neurological Disorders and Stroke in April 2022.
- 131 participants recruited by the time of manuscript submission.
Conclusions:
- This is the largest study to date on PD phenotype and management in Black patients in the US.
- Planned collaborations will enhance understanding of genetic risk factors in this understudied population.
- Findings may inform strategies to reduce health disparities in PD care.
Related Concept Videos
Parkinson's Disease: Overview
360
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
360
Parkinson's Disease: Treatment
163
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
163
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Human Genetics
502
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
502
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
311
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
311

